Supplied byUWA Biotech
Supplier locationUnited States
Dispatch1–2 business days
VerificationReport available
Public report information
Review the testing reference and connected report information before viewing the supplier listing.
Research product overview
Product details supplied through the connected marketplace listing.
Product overview
Tirzepatide is a dual GIP and GLP-1 pathway research peptide supplied by UWA Biotech for laboratory investigations involving metabolic signalling, incretin receptor activity, peptide pharmacology and advanced obesity and metabolic research applications.
Available formats
- 10 × 5mg
- 10 × 10mg
- 10 × 15mg
- 10 × 20mg
- 10 × 30mg
- 10 × 60mg
- MOQ: 10 vials / 1 box
Verification
- Purity: 99.688%
- Tested: 25 FEB 2026
- Task number: #110143
- Unique key: 5IVMYW1E5G18
Research applications
- GLP-1 pathway research
- GIP receptor investigations
- Metabolic signalling studies
- Incretin peptide research
This product is supplied exclusively for laboratory research use. Not for human consumption, therapeutic use or clinical application.
This listing is provided for laboratory and research sourcing review. It is not intended for human consumption, medical use or self-administration.